Moreover, targeting the CXCL12-mediated axis can control tumors and the tumor microenvironment by playing dual roles inanti-tumor15, Zhou16 demonstrated that the CXCL12/CXCR4 axis can be used as a molecular target for cancer therapy. The gene discussed is CXCL12; the disease is neoplasm.